Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Gedea Biotech

Gedea logo

 

Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Gedea Biotech's substance is a natural substance, known to be harmless and is now formulated into an easy-to-use treatment. Behind the idea lies years of basic research from an interdisciplinary research group, and in 2017 the project won first prize in Lund University and Sparbanksstiftelsen Finn's Award for Future Innovations.

Gedea Biotech is founded by Olov Sterner, professor at the Faculty of Science, Helena Strevens, specialist physician in Gynaecology and Obstetrics as well as researcher at the Faculty of Medicine and Ulf Ellervik and Sophie Manner, both chemists at LTH.

Gedea Biotech's website

 

 

Gedea Biotech

Founded by Helena Strevens, Olov Sterner, Ulf Ellervik and Sophie Manner.

Portfolio company since 2016.

 

Portfolio Manager LU Holding: 

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78